Alar Pharmaceuticals Statistics
Total Valuation
TPEX:6785 has a market cap or net worth of TWD 8.88 billion. The enterprise value is 6.45 billion.
Market Cap | 8.88B |
Enterprise Value | 6.45B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 16.08% in one year.
Current Share Class | n/a |
Shares Outstanding | 66.80M |
Shares Change (YoY) | +16.08% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 24.57% |
Owned by Institutions (%) | 4.97% |
Float | 36.19M |
Valuation Ratios
The trailing PE ratio is 488.96.
PE Ratio | 488.96 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 3.57 |
P/TBV Ratio | 3.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 355.20 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -92.41 |
Financial Position
The company has a current ratio of 44.33, with a Debt / Equity ratio of 0.00.
Current Ratio | 44.33 |
Quick Ratio | 44.14 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -2,516.44 |
Financial Efficiency
Return on equity (ROE) is 1.07% and return on invested capital (ROIC) is -2.50%.
Return on Equity (ROE) | 1.07% |
Return on Assets (ROA) | -2.41% |
Return on Invested Capital (ROIC) | -2.50% |
Return on Capital Employed (ROCE) | -2.72% |
Revenue Per Employee | 215,444 |
Profits Per Employee | 672,963 |
Employee Count | 22 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.00% in the last 52 weeks. The beta is 0.12, so TPEX:6785's price volatility has been lower than the market average.
Beta (5Y) | 0.12 |
52-Week Price Change | -60.00% |
50-Day Moving Average | 144.31 |
200-Day Moving Average | 175.58 |
Relative Strength Index (RSI) | 35.98 |
Average Volume (20 Days) | 261,672 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6785 had revenue of TWD 5.82 million and earned 18.17 million in profits. Earnings per share was 0.27.
Revenue | 5.82M |
Gross Profit | 3.79M |
Operating Income | -67.94M |
Pretax Income | 37.05M |
Net Income | 18.17M |
EBITDA | -65.43M |
EBIT | -67.94M |
Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 2.43 billion in cash and 604,000 in debt, giving a net cash position of 2.43 billion or 36.38 per share.
Cash & Cash Equivalents | 2.43B |
Total Debt | 604,000 |
Net Cash | 2.43B |
Net Cash Per Share | 36.38 |
Equity (Book Value) | 2.49B |
Book Value Per Share | 37.30 |
Working Capital | 2.39B |
Cash Flow
In the last 12 months, operating cash flow was -37.67 million and capital expenditures -32.17 million, giving a free cash flow of -69.84 million.
Operating Cash Flow | -37.67M |
Capital Expenditures | -32.17M |
Free Cash Flow | -69.84M |
FCF Per Share | -1.05 |
Margins
Gross margin is 65.15%, with operating and profit margins of -1,168.02% and 312.36%.
Gross Margin | 65.15% |
Operating Margin | -1,168.02% |
Pretax Margin | 636.91% |
Profit Margin | 312.36% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.19%.
Dividend Per Share | 0.25 |
Dividend Yield | 0.19% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 551.46% |
Buyback Yield | -16.08% |
Shareholder Yield | -15.89% |
Earnings Yield | 0.20% |
FCF Yield | -0.79% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6785 has an Altman Z-Score of 145.54.
Altman Z-Score | 145.54 |
Piotroski F-Score | n/a |